LOS ANGELES, Aug. 9 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") today announced that the Company will host a conference call on Tuesday, August 15, 2006 at 6:00 a.m. PT (9:00 a.m. ET) to discuss results for the second quarter of 2006.
Joining Ms. Zhilin Li, President and CEO of China Pharma, will be Mr. Xinhua Wu, Chief Financial Officer, and Mr. Donald Xu, Vice President, Strategic Planning and Business Development. The Company plans to distribute its earnings announcement earlier that same day.
To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (888) 419- 5570. International callers should dial (617) 896-9871. The conference passcode is 84660865.
If you are unable to participate in the call at this time, a replay will be available on Tuesday, August 15 at 10:30 a.m. ET, through Tuesday, August 22 at 10:30 a.m. ET. To access the replay, dial (888) 286-8010. International callers should dial (617) 801-6888. The conference passcode is 84660865.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty bio-pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, which may include, but are not limited to, such factors as unanticipated changes in product demand, increased competition, failure to obtain or maintain intellectual property protection, downturns in the Chinese economy, uncompetitive levels of research and development, failure to obtain regulatory approvals, and other information detailed from time to time in the Company's filings and future filings with the United States Securities and Exchange Commission.
Contact: Crocker Coulson President CCG Elite 10960 Wilshire Boulevard, Suite 2050 Los Angeles, California 90024 310 231-8600 ext 103 323 270-8886 (cell) 323 350-2793 (cell2) crocker.coulson@ccgir.com or Donald Xu Vice President, Strategic Planning and Business Development China Pharma Holdings, Inc. P.O. Box 501350 San Diego, California, 92150 858-776-8880 dxu@chinapharmaholdings.com
China Pharma Holdings, Inc.
CONTACT: Crocker Coulson, President, CCG Elite, +1-310 231-8600 ext 103,cell, +1-323 270-8886, cell2, +1-323-350-2793, crocker.coulson@ccgir.com;Donald Xu, Vice President, Strategic Planning and Business Development,China Pharma Holdings, Inc., +1-858-776-8880, dxu@chinapharmaholdings.com
